Literature DB >> 8423946

Fetal serum and amniotic fluid magnesium concentrations with maternal treatment.

M Hallak1, S M Berry, F Madincea, R Romero, M I Evans, D B Cotton.   

Abstract

OBJECTIVE: To determine the effect of maternal intravenous (IV) magnesium sulfate administration on fetal serum and amniotic fluid (AF) concentrations of magnesium.
METHODS: Thirty-six patients underwent fetal blood sampling for prenatal diagnosis of one of several abnormal conditions. Fifteen subjects had uterine contractions at the time of funipuncture and received IV magnesium sulfate therapy to quiet the uterus before the procedure. Three groups of subjects were defined: 21 untreated controls, ten women who received magnesium treatment for 1 hour, and five who received it for 3 hours before fetal blood sampling. Magnesium concentrations in maternal and fetal serum and AF were compared among the three groups.
RESULTS: Patients who received magnesium sulfate for 1 and 3 hours had significantly higher concentrations of serum magnesium (4.11 +/- 0.6 and 5.54 +/- 0.2 mg/dL, respectively) than untreated subjects (1.77 +/- 0.2 mg/dL) (P < .0001). Fetal serum magnesium concentrations were significantly higher in the 1- and 3-hour groups (2.48 +/- 0.1 and 4.44 +/- 0.2 mg/dL, respectively) than in controls (1.67 +/- 0.2 mg/dL) (P < .0001). The AF magnesium concentration was significantly increased only after 3 hours of elevated maternal magnesium levels (1.45 +/- 0.2 and 2.84 +/- 0.2 mg/dL in controls and 3-hour group, respectively; P < .0001). The correlation between maternal and fetal blood magnesium concentrations was highly significant (r = 0.89; P < .0001), as was the correlation between fetal serum and AF concentrations (r = 0.84; P < .0001).
CONCLUSION: Magnesium levels increase in fetal serum within 1 hour and AF within 3 hours after maternal IV administration.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8423946

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  11 in total

1.  Lack of Evidence for Time or Dose Relationship between Antenatal Magnesium Sulfate and Intestinal Injury in Extremely Preterm Neonates.

Authors:  Michel Mikhael; Cheryl Bronson; Lishi Zhang; Mark Curran; Helen Rodriguez; Kushal Y Bhakta
Journal:  Neonatology       Date:  2019-04-09       Impact factor: 4.035

Review 2.  Fetal drug therapy.

Authors:  M I Evans; P G Pryde; A Reichler; M Bardicef; M P Johnson
Journal:  West J Med       Date:  1993-09

3.  Magnesium sulfate tocolysis and intraventricular hemorrhage in very preterm infants.

Authors:  Anna Petrova; Rajeev Mehta
Journal:  Indian J Pediatr       Date:  2011-05-28       Impact factor: 1.967

4.  Effects of antenatal magnesium sulfate treatment for neonatal neuro-protection on cerebral oxygen kinetics.

Authors:  Michael J Stark; Nicolette A Hodyl; Chad C Andersen
Journal:  Pediatr Res       Date:  2015-05-18       Impact factor: 3.756

Review 5.  Management of clinical chorioamnionitis: an evidence-based approach.

Authors:  Agustin Conde-Agudelo; Roberto Romero; Eun Jung Jung; Ángel José Garcia Sánchez
Journal:  Am J Obstet Gynecol       Date:  2020-09-29       Impact factor: 8.661

6.  Maternal magnesium sulphate exposure predicts neonatal magnesium blood concentrations.

Authors:  Catherine M T Sherwin; Alfred Balch; Sarah C Campbell; Jeunesse Fredrickson; Erin A S Clark; Michael Varner; Chris Stockmann; E Kent Korgenski; Joshua L Bonkowsky; Michael G Spigarelli
Journal:  Basic Clin Pharmacol Toxicol       Date:  2013-12-11       Impact factor: 4.080

7.  A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy.

Authors:  Dwight J Rouse; Deborah G Hirtz; Elizabeth Thom; Michael W Varner; Catherine Y Spong; Brian M Mercer; Jay D Iams; Ronald J Wapner; Yoram Sorokin; James M Alexander; Margaret Harper; John M Thorp; Susan M Ramin; Fergal D Malone; Marshall Carpenter; Menachem Miodovnik; Atef Moawad; Mary J O'Sullivan; Alan M Peaceman; Gary D V Hankins; Oded Langer; Steve N Caritis; James M Roberts
Journal:  N Engl J Med       Date:  2008-08-28       Impact factor: 91.245

8.  Antenatal Magnesium Sulfate, Necrotizing Enterocolitis, and Death among Neonates < 28 Weeks Gestation.

Authors:  Manijeh Kamyar; Erin A S Clark; Bradley A Yoder; Michael W Varner; Tracy A Manuck
Journal:  AJP Rep       Date:  2016-03

9.  Magnesium sulfate has sex-specific, dose-dependent vasodilator effects on preterm placental vessels.

Authors:  Clint Gray; Mark H Vickers; Rebecca M Dyson; Clare M Reynolds; Mary J Berry
Journal:  Biol Sex Differ       Date:  2015-11-04       Impact factor: 5.027

Review 10.  Fetal Neuroprotection by Magnesium Sulfate: From Translational Research to Clinical Application.

Authors:  Clément Chollat; Loïc Sentilhes; Stéphane Marret
Journal:  Front Neurol       Date:  2018-04-16       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.